Application Nr Approved Date Route Status External Links
BLA761125 None Intravitreal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Beovu ® Is Indicated For The Treatment Of Neovascular (Wet) Age-Related Macular Degeneration (Amd). Beovu Is A Human Vascular Endothelial Growth Factor (Vegf) Inhibitor Indicated For The Treatment Of Neovascular (Wet) Age-Related Macular Degeneration (Amd) ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brolucizumab

Comments